More on OKYO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OKYO Pharma (NQ:OKYO)
Delayed: 1.49 --0 (-0%)
Prev. Close $1.49  
Open$1.49 
52 Wk High$ 
52 Wk Low$ 
Day High$1.54 
Day Low$1.40 
P/E N/A  
EPS$ 
Volume24,653 

Friends, Peers and Foes (?): OK11 (more...)

Oct 7, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on OKYO Pharma Ltd. (OKYO)
Oct 6, 2026 07:00 AM Form 6-K OKYO Pharma Ltd For: Oct 06
Oct 6, 2026 07:00 AM OKYO Pharma enrolls first patients in Phase 3 corneal pain trial
Oct 6, 2026 07:00 AM OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Sep 29, 2026 07:00 AM Form 6-K OKYO Pharma Ltd For: Sep 29
Sep 29, 2026 07:00 AM OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
Sep 9, 2026 07:00 AM OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
Sep 8, 2026 07:00 AM OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
Aug 7, 2026 04:31 PM Form 20-F/A OKYO Pharma Ltd For: Mar 31
Aug 7, 2026 04:17 PM Form 4/A OKYO Pharma Ltd For: Jul 21 Filed by: BRANCACCIO JOHN P
View All Articles

Entities mentioned with OKYO

View All Entities